Rarity offers ultra-sensitive and multiplexed mutation detection on 21 of the most common KRAS hotspot mutations for liquid biopsy research.
To see our Multiplex KRAS superRCA assays, and explore all our assays:
Analyzing KRAS mutations in cancer is crucial for understanding the underlying mechanisms of tumor growth. These mutations, prevalent in cancers like colorectal, lung, and pancreatic, drive uncontrolled cell proliferation.
The superRCA KRAS multiplex panel is also available in tumor oriented multiplex combinations with other genes, such as NRAS, PIK3CA, BRAF, and AKT1.
Additional variants available on request, reach out to us through this form and we will help you further!